Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cutaneous neoplasms benign
ADR ID BADD_A04052
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.26      Cutaneous neoplasms benign
23      Skin and subcutaneous tissue disorders
23.10      Cutaneous neoplasms benign
Description Not Available
MedDRA Code 10040899
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02018Sildenafil0.000161%
BADD_D02028Sirolimus--
BADD_D02031Sitaxentan--
BADD_D02047Sodium oxybate0.000268%
BADD_D02058Sorafenib0.001287%
BADD_D02100Sunitinib0.000168%
BADD_D02105Tacrolimus0.005644%
BADD_D02150Temozolomide0.000112%
BADD_D02192Thalidomide--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02223Tiopronin--
BADD_D02236Tofacitinib0.008632%
BADD_D02254Tramadol--
BADD_D02257Trametinib--
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02321Ursodiol--
BADD_D02329Valproic acid0.000300%
BADD_D02331Valsartan0.000079%
BADD_D02344Vemurafenib0.014607%
BADD_D02369Voriconazole0.024396%
BADD_D02373Warfarin0.000028%
BADD_D02397Zopiclone--
BADD_D02407Upadacitinib0.001350%
BADD_D02436Atorvastatin0.000010%
BADD_D02450Crisaborole0.001596%
BADD_D02464Fingolimod0.067150%
BADD_D02492Deflazacort0.000117%
BADD_D02511Siponimod0.000651%
BADD_D02591Ripretinib0.000627%
The 4th Page    First    Pre   4    Total 4 Pages